Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Health Insurance Knee Replacement Coverage | O…
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0014-1812

    Knee Replacement Surgery Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0014-1812 alerts

    Get alerted when Policy PUM 250-0014-1812 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs medical-necessity coverage for knee arthroplasty procedures and related services for knee osteoarthritis and other specified knee conditions. Coverage depends on the stated clinical criteria, documentation, device requirements, benefit plan terms, and applicable law.

    Policy Summary
    PayerWPS Health Insurance
    PolicyKnee Replacement Surgery Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionDocument a trial of analgesic or anti-inflammatory medication for at least 2 weeks without improvement for degenerative joint disease, unless contraindicated.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    9Listed qualifying clinical indications
    ≥ 2 weeksMedication trial for degenerative joint disease
    ≥ 6/10Qualifying average pain level
    ≤ 29Qualifying Oxford knee score

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Customization qualifying situations
    FDA-approvedRequired device status

    Knee Arthroplasty Coverage Criteria

    Standard knee arthroplasty indications

    Knee arthroplasty is medically necessary when at least one of the following indications is met. The degenerative joint disease indication requires all applicable subcriteria.

    Qualifying indications

    • Degenerative joint disease

      • DJD prerequisites

        • Medication trial and objective arthritis

          • Analgesic or anti-inflammatory medication trial: The individual has trialed analgesic or anti-inflammatory medication for at least 2 weeks without improvement, unless contraindicated.At least 2 weeks without improvement, unless contraindicated
          • Radiographic or arthroscopic evidence: Moderate to severe arthritis is shown on radiographic imaging or prior arthroscopy.
      • ONE of: pain, functional disability, or Oxford knee score

        • Pain threshold: Average pain level is 6 or greater on a scale of 0 to 10.≥ 6/10
        • Functional disability: Intermittent or continuous pain is causing a functional disability that interferes with activities of daily living.
        • Oxford knee score is 29 or less.≤ 29
    • Other qualifying indications

      • Failure of previous knee arthroplasty or osteotomy that is causing pain or functional disability that interferes with activities of daily living.
      • Revision or replacement of a previous knee arthroplasty is needed due to loosening or instability of the implant, osteolysis, infection of the artificial joint, periprosthetic fracture, or patellar dislocation.
      • Fracture of the proximal tibia or distal femur, or radiographic imaging showing nonunion or malunion of a previous fracture, is causing pain or functional disability that interferes with activities of daily living.
      • Proximal tibial, distal femur, knee, or adjacent-tissue malignancy.
      • Destruction of the knee joint caused by traumatic injury or prior infection.
      • Hemophilic or inflammatory arthropathy

    Customized prostheses and patient-specific instruments

    Customized prostheses and/or patient-specific cutting instruments are medically necessary only when the standard knee-replacement criteria are met, the device is FDA-approved, and at least one additional qualifying condition is present.

    Customized prosthesis or patient-specific instruments

    • The standard knee-replacement medical-necessity criteria are met.
    • The knee arthroplasty uses an FDA-approved device.
    • ONE additional qualifying condition

      • Destruction of the knee joint caused by traumatic injury, prior infection, or inflammatory or hemophilic arthropathy.
      • Severe congenital deformity.

    Patient-specific surgical instruments are not medically necessary unless the qualifying customized-prosthesis indications are met. The underlying knee-replacement criteria must be satisfied, and the patient must have a qualifying condition such as traumatic or prior-infection joint destruction, inflammatory or hemophilic arthropathy, severe congenital deformity, complex peri-articular fracture, or fracture through a previous prosthesis.

    Customized knee implants, including Conformis iTotal CR and other Conformis knee replacement systems, are not medically necessary unless the standard knee-replacement criteria and an additional qualifying customized-prosthesis indication are met. CT or MRI used to manufacture a custom prosthesis, plan patient-specific instruments, or plan intraoperative navigation is likewise not medically necessary except under the stated indications.

    Intraoperative surgical navigation and robotic assistance for knee arthroplasty—including MAKO, KneeAlign, iAssist, Velys Digital Surgery, and similar systems—are considered integral to the surgical procedure.

    Knee replacement for a condition listed in the indications of coverage is considered not medically necessary when the stated coverage criteria are not met. A condition or diagnosis not listed in the indications of coverage is considered experimental, investigational, and unproven to affect health outcomes.

    Coverage of patient-specific instruments, customized implants, and associated CT or MRI or other planning services requires that the standard knee-replacement criteria be met and that at least one qualifying condition be documented: traumatic or prior-infection joint destruction, inflammatory or hemophilic arthropathy, severe congenital deformity, complex peri-articular fracture, or fracture through a previous prosthesis. Otherwise, these services are not medically necessary.

    Clinical Thresholds and Coding Parameters

    Analgesic or anti-inflammatory medication trial
    Required trialAnalgesic or anti-inflammatory medication must be tried for at least 2 weeks.
    Required resultThe trial must occur without improvement.
    ExceptionThe medication trial is not required when contraindicated.
    Average pain level
    Qualifying thresholdAverage pain level of 6 or greater.
    Measurement scalePain is measured on a scale of 0 to 10.
    Coverage context

    Documentation and Coverage Risk Checks

    Documentation Required

    Document Conservative Medication Trial

    For degenerative joint disease, document a trial of analgesic or anti-inflammatory medication for at least 2 weeks without improvement, unless the medication is contraindicated. Include the medication trial, response, and any contraindication in the medical record.

    • At least 2 weeks of analgesic/anti-inflammatory therapy without improvement, unless contraindicated.
    • Document the medication(s), treatment duration, response, and contraindication when applicable.
    Documentation Required

    Submit Complete Medical-Necessity Documentation

    Before requesting coverage, submit the required order and records establishing the diagnosis, medical necessity, applicable indications, and treatment history. Records should support the patient’s pain, functional impairment, imaging findings, and conservative treatment trials.

    • Standard Written Order (SWO) from a qualified healthcare provider concerning the member’s diagnosis.
    • History and physical notes documenting knee-related pain and physical or functional impairments, plus imaging studies.

    Policy Background

    Knee arthroplasty replaces damaged or diseased knee-joint surfaces with artificial implants. This guideline addresses total, patellofemoral, bicompartmental, and unicompartmental knee arthroplasty when pain, functional disability, structural joint disease, fracture, deformity, infection, malignancy, or arthropathy meets the applicable coverage criteria.

    Key Definitions

    Knee replacement surgery
    DefinitionReplacement of the damaged or diseased surfaces of the knee joint with artificial, man-made implants.
    Also calledKnee arthroplasty.
    Included proceduresTotal knee arthroplasty, patellofemoral arthroplasty, bicompartmental knee arthroplasty, and unicompartmental knee arthroplasty.
    Functional disability
    DefinitionA functional disability that interferes with activities of daily living.
    AbbreviationActivities of daily living are abbreviated as ADLs.
    Coverage application
    Policy Summary
    PayerWPS Health Insurance
    PolicyKnee Replacement Surgery Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionDocument a trial of analgesic or anti-inflammatory medication for at least 2 weeks without improvement for degenerative joint disease, unless contraindicated.
    SourceLink
    On This Page
    Knee Arthroplasty Coverage CriteriaClinical Thresholds and Coding ParametersDocumentation and Coverage Risk ChecksPolicy BackgroundKey Definitions
    Advanced arthritic changes are documented.
  1. The joint space is severely narrowed.
  2. Decreased range of motion is documented.
  3. Pain or functional disability interferes with activities of daily living.
  4. Other surgical interventions, including synovectomy, arthrodesis, or osteotomy, are not appropriate or have failed.
  5. Congenital deformity is causing pain or functional disability that interferes with activities of daily living.
  6. Repair of a distal-femur fracture due to osteoporosis in an elderly individual is needed when open reduction internal fixation is not appropriate or has been unsuccessful.
  7. Complex peri-articular fracture or fracture through a previous prosthesis.
    This is one of the qualifying pain, disability, or Oxford knee score criteria for degenerative joint disease.
    Oxford knee score
    Qualifying thresholdOxford knee score of 29 or less.
    AbbreviationOxford knee score is abbreviated as OKS.
    Coverage contextThis is one of the qualifying pain, disability, or score criteria for degenerative joint disease.
  8. Medical records supporting medical necessity and continued need or use, when applicable.
  9. Documentation of conservative treatment trials, including medication, physical therapy, and weight loss when indicated.
  10. Use correct coding that meets all applicable coding guidelines.
  11. Documentation Required

    Document Device Approval and Customization Criteria

    When customized or patient-specific technology is proposed, document FDA approval and the specific indication supporting its use. Customized prostheses, patient-specific instruments, and related CT or MRI studies are medically necessary only when the applicable qualifying indication is documented.

    • The surgeon is responsible for confirming that the device or prosthetic is FDA-approved.
    • For an FDA-approved device with a customized prosthesis and/or patient-specific instruments, document that the standard knee-replacement criteria are met and that one qualifying indication applies: traumatic injury, prior infection, or inflammatory/hemophilic arthropathy causing joint destruction; severe congenital deformity; or complex peri-articular fracture or fracture through a previous prosthesis.
    • Document moderate to severe arthritis on radiographic imaging or prior arthroscopy when required for degenerative joint disease.
    • Document the applicable pain or functional-disability evidence, such as average pain of 6 or greater, pain interfering with activities of daily living, or an Oxford knee score of 29 or less.
    • For hemophilic or inflammatory arthropathy, document advanced arthritic changes, severely narrowed joint space, decreased range of motion, pain or functional disability interfering with activities of daily living, and that synovectomy, arthrodesis, or osteotomy is inappropriate or has failed.
    • CT or MRI designed to manufacture custom prostheses or patient-specific instruments is medically necessary only for one of the qualifying indications above.
    Denial Risk

    Unlisted Indication: Experimental or Unproven

    If the knee replacement is used for a condition or diagnosis not listed in the indications of coverage, it is considered experimental, investigational, and unproven to affect health outcomes.

    • Verify that the diagnosis is listed in the Indications of Coverage before proceeding.
    • Unlisted indications are not covered as medically necessary under this guideline.
    Denial Risk

    Criteria Not Met: Not Medically Necessary

    A listed condition or diagnosis does not establish coverage by itself. If the applicable medical-necessity criteria are not met, the knee replacement is considered not medically necessary.

    • Document every required criterion for the applicable indication.
    • For degenerative joint disease, verify the medication trial or contraindication, imaging or arthroscopy findings, and required pain or functional-disability evidence.
    • Confirm that any additional indication-specific requirements are satisfied before requesting coverage.
    Denial Risk

    Verify FDA Approval for Specific Use

    Use only a device or prosthetic that is approved by the U.S. Food and Drug Administration for the specific procedure or planned use. The surgeon is responsible for verifying and documenting this approval.

    • A device or prosthetic not FDA-approved for the specific procedure or planned use is experimental, investigational, and unproven.
    • FDA approval for a different procedure or use does not satisfy this requirement.
    Denial Risk

    Excluded Technology or Adjunct

    Do not bill customized technology or adjunctive services as covered unless the guideline’s specific exception is met. Patient-specific instruments, customized implants, custom-prosthesis planning imaging, and the listed adjunctive technologies are excluded or unproven as described below.

    • Patient-specific surgical instruments are not medically necessary except for the qualifying indications under Indications of Coverage.
    • Customized knee implants, including Conformis iTotal CR® and other Conformis knee replacement systems, are not medically necessary except for the qualifying indications.
    • CT or MRI used to manufacture custom prostheses, create patient-specific instruments, or plan intraoperative navigation is not medically necessary except for the qualifying indications.
    • Postoperative prophylactic radiation therapy; bi-unicompartmental, bicompartmental, or staged bicompartmental arthroplasty; home CPM devices and related equipment; iovera®; Unispacer; Coolief® Cooled RF; cryotherapy; joint-unloading implants such as KineSpring® and Atlas®; viscosupplementation or hyaluronic acid injections such as Orthovisc® and Synvisc®; stem-cell therapy or injections; peripheral nerve block or ablation other than femoral or adductor canal block; platelet-rich plasma injections; genicular nerve blocks or injections except when provided intraoperatively; genicular nerve radiofrequency ablation; mi-eye 2 Camera-Enabled Probe; intraoperative kinetic-balance sensors such as Verasense®; BMAC; MFAT such as Lipogems®; platelet lysate; Apos Therapy System; 3D-print orthopaedic implants; and subchondral calcium phosphate injections (subchondroplasty) are experimental, investigational, and unproven.
    • Intraoperative surgical navigation, including MAKOplasty/MAKO® Tactile Guidance System, KneeAlign®, iAsssit® Knee System, Velys Digital Surgery, and robotic assistance such as Mako robotic-assisted surgery, is integral to the knee-arthroplasty procedure and is not separately covered.
    Pain causing functional disability that interferes with ADLs is a qualifying criterion for several knee arthroplasty indications.
    Qualifying Oxford knee score
    Qualifying scoreOxford knee score of 29 or less.
    AbbreviationOxford knee score is abbreviated as OKS.
    Coverage applicationAn Oxford knee score of 29 or less is one qualifying symptom or function threshold for degenerative joint disease.